Al-Hajali and Abdel-Razeq lead CellSave Arabia, which was founded in 2005. It operates today across the U.A.E., Qatar, and the wider GCC. Key milestones in 2024 include AABB accreditation for somatic cells in April 2024, launching the expansion of ready to be used mesenchymal stem cells in July, and expanding into Qatar through Sidra Medicine in November. CellSave is set to introduce adult stem cell storage in 2025, further contributing to the regenerative medicine market.